EDC for longevity clinical trials: aging and longevity endpoints, ePRO, and 21 CFR Part 11–aligned controls.
21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required
Overview
Longevity clinical trials study interventions aimed at aging, healthspan, and related biomarkers and outcomes. Your EDC must support consent, CRFs, optional ePRO and patient-reported outcomes, biomarker and lab data, and full auditability for regulatory and publication use. Capture provides EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned infrastructure, so longevity study teams can capture clinical and PRO data with one audit trail.
Longevity studies often combine biomarkers, functional assessments, and patient-reported outcomes. You need one system that handles consent, CRFs, and ePRO with the same audit trail and access controls. Legacy EDC may lack flexibility for emerging longevity endpoints. Capture is built for flexible study designs with controls aligned with 21 CFR Part 11 and HIPAA-aligned security.
FAQ
Explore the platform with a free sandbox. No sales call required.